https://www.biospace.com/sangamo-biosciences-inc-announces-breakthrough-results-at-icaac-demonstrating-protection-of-cells-from-hiv-infection-following-treatment-with-zinc-f
Sangamo BioSciences, Inc. Announces Breakthrough Results At ICAAC Demonstrating Protection Of Cells...
sangamo biosciences
https://www.prnewswire.com/news-releases/sangamo-biosciences-announces-presentation-at-the-jefferies-2015-global-healthcare-conference-300088687.html
Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference
/PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the...
sangamo biosciencesglobal healthcareannouncespresentation
https://www.biospace.com/sangamo-biosciences-reports-fourth-quarter-and-full-year-2014-financial-results-633941
Sangamo BioSciences Reports Fourth Quarter And Full Year 2014 Financial Results - BioSpace
sangamo biosciencesfourth quarter
https://www.biospace.com/sangamo-biosciences-presents-new-clinical-data-at-croi-2015-from-trial-of-zfp-therapeutic-designed-to-provide-functional-control-of-hiv
Sangamo BioSciences Presents New Clinical Data At CROI 2015 From Trial Of ZFP Therapeutic Designed...
https://www.biospace.com/sangamo-biosciences-inc-announces-fda-acceptance-of-ind-to-initiate-clinical-trial-of-its-novel-zfp-therapeutic-and-174-for-beta-thalassemia
Sangamo BioSciences, Inc. Announces FDA Acceptance Of IND To Initiate Clinical Trial Of Its Novel...